The clinical use of psychotherapeutic drugs in the elderly.
D000368:Aged; D000375:Aging; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000188:drug therapy; D002090:Butyrophenones / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D019965:Neurocognitive Disorders / Q000188:drug therapy; D010640:Phenothiazines; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D008094:Lithium; D006220:Haloperidol